Jan 11, 2022 / 06:30PM GMT
Casey Rene Woodring - JPMorgan Chase & Co, Research Division - Research Analyst
Okay. Hi. My name is Casey Woodring from the Life Science Tools equity research team here at JPM. Welcome to our Annual Healthcare Conference. I'm pleased to introduce our next company in Hologic. (Operator Instructions)
So with that, I'll turn it over to Steve. Steve?
Stephen P. MacMillan - Hologic, Inc. - Chairman, CEO & President
Thanks Casey, for having us. And I'm sorry, we're not there in person because I only wish that my excitement and enthusiasm for how strong we are as a company today and the difference we're making in the world can fully come through for those of you who are largely probably watching this on a computer screen. And I just don't think it can fully come through as well as we would like it to for what we're doing as a company.
So if you pardon me, I'm not going to read every word of the safe harbor statement. I think we'll just jump right through that since we've got a lot to cover here today. And I'm going to jump right here to
Hologic Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot